June 2, 2023 — Anxiety, depression, and COVID-19 can be a bad combination for your brain — and your long-term health. Having anxiety and depression before a COVID infection increases the risk of developing long COVID, researchers have found. Those with long COVID who develop anxiety and depression after an infection may have brain shrinkage in areas …
Anxiety, Your Brain, and Long COVID: What the Research Says Read More »
By Tauseef Ali, MD as told to Marijke Vroomen Durning, RN Managing patients with a chronic condition like Crohn’s disease is challenging professionally and personally. I’ve been working with this population and people with other gastrointestinal disorders for more than 15 years now. But as challenging as the work can be, it is gratifying when I …
Doctor: What My Patients Have Taught Me About Crohn’s Read More »
By Randy Longman, MD, as told to Marijke Vroomen Durning, RN I’ve been working with patients with inflammatory bowel disease (IBD), which includes Crohn’s disease, for about 15 years now. Treating patients with chronic illnesses like Crohn’s disease can be challenging, but it’s also very rewarding. As their doctor, I have a unique opportunity to …
Doctors, Researchers Work Hard to Improve Crohn’s Disease Treatments Read More »
WebMD has hidden the identity and location of Mary M. and Andrew in order to protect the mental health and safety of Andrew and his family. It’s May 13, 2022, and Mary M. is in a panic. Just a day earlier, a hospital admitted her adult son Andrew in a deep state of psychosis. Against …
Schizophrenia: Fighting the FDA for Clozapine Access Read More »
Berlin, Germany and Boston, US, June 1, 2023 – Bayer and Cedilla Therapeutics, a biotechnology company bringing a new dimension to precision oncology, today announced an exclusive license agreement to develop and commercialize Cedilla Therapeutics’ CyclinE1/CDK2 complex inhibitors which selectively address oncogenic drivers. Overexpression or genetic activation of Cyclin Dependent Kinase 2 (CDK2) binding partner …
Not intended for U.S. and UK Media Berlin, June 1, 2023 – Bayer and its development partner MSD (a tradename of Merck & Co., Inc., Rahway, NJ, USA) today announced that the first patient has been enrolled in the Phase II/III VALOR trial. VALOR will investigate the efficacy, safety, and pharmacokinetics of vericiguat (Verquvo™) in …
Bayer starts phase II/III study with vericiguat in children with heart failure Read More »
With more ways than ever to measure metrics—core temperature, HRV, oxygen saturation, sweat rate, heart rate and, of course, speed—some athletes feel like they just can’t train without data feedback. “If you can measure it, you can improve it,” the saying goes. “Data is part of the game,” Fabian Cancellara said on Wednesday at the …
Welcome to MH Certified, where Men’s Health puts its stamp of approval on the best products you need to look, feel, and live better than ever before. GATHER ‘ROUND for a tale of love, self-discovery, and a pair of sneakers that has, well, reshaped my daily life. (Too dramatic? A bit. Deceitful? Absolutely not.) You …
MH Certified: Cariuma’s OCA Low Is the Only Everyday Fashion Sneakers You Need Read More »
With more ways than ever to measure metrics—core temperature, HRV, oxygen saturation, sweat rate, heart rate and, of course, speed—some athletes feel like they just can’t train without data feedback. “If you can measure it, you can improve it,” the saying goes. “Data is part of the game,” Fabian Cancellara said on Wednesday at the …
Welcome to MH Certified, where Men’s Health puts its stamp of approval on the best products you need to look, feel, and live better than ever before. GATHER ‘ROUND for a tale of love, self-discovery, and a pair of sneakers that has, well, reshaped my daily life. (Too dramatic? A bit. Deceitful? Absolutely not.) You …
MH Certified: Cariuma’s OCA Low Is the Only Everyday Fashion Sneakers You Need Read More »